Gabapentin|Rebamipide|Venlafaxine HCI|Aceclofenac|Candesartan Cilexetil---Jiangxi Synergy Pharmaceut

Headquarter:

Add: Jiangxi Fengxin Industrial Park, Fengxin,Jiangxi,P.R.China

Tel: +86-795-4605771,4605608

Fax: +86-795-4605772

Post Code: 330700

Sales & Marketing:

Room 1901, Tower A, Yuanshen Financial Building, NO. 355 Yuanshen Road, Pudong New Area, Shanghai China

Tel:+86-21-62886322

Post Code: 200135

Products

New Product	Indication	CAS	Specification	GMP	Documentation
Apixaban	Anti-thrombotics	503612-47-3	in house	local GMP, WC	USDMF #32781
Edoxaban Tosylate	Anti-thrombotics	1229194-11-9	in house	local GMP, WC processing	ODMF available
Empagliflozin	Anti-diabetes	864070-44-0	in house	local GMP, WC	ODMF available, ASMF in processing
Canagliflozin	Anti-diabetes	842133-18-0	in house	local GMP	ODMF available
Dapagliflozin	Anti-diabetes	461432-26-8	in house	local GMP	DMF processing
Ipragliflozin	Anti-diabetes	761423-87-4	in house	local GMP	DMF processing
Mirabegron	Urology	223673-61-8	in house	local GMP, WC	USDMF #31661, ASMF in processing
Vibegron	Urology	1190389-15-1	in house	local GMP	DMF processing
Azilsartan KaMedoximil	Anti-hypertension	863031-21-4	in house	local GMP, WC	ODMF available, ASMF in processing
Vonoprazan Fumarate	Gastrointestinology	1260141-27-2	in house	local GMP, WC	ODMF available
Agomelatine	Anti-depressants	138112-76-2	in house	local GMP	ODMF available by Dec, 2022
Crisaborole	Atopic Dermatitis	906673-24-3	in house	local GMP	ODMF available by Dec, 2022
Roxadustat	Anemia	808118-40-3	in house	local GMP	ODMF available in Q1, 2023
Apabetalone	Hypolipidemic agents	1044870-39-4	in house	local GMP	DMF processing
Relugolix	prostate cancer; endomotriosis	737789-87-6	in house	local GMP	ODMF available in Q1, 2023

15 Records